Addressing sexual health after cancer: whose job is it anyway? Provider practices and communication barriers
Supportive Care in Cancer · 2026-10 · 34 (10)
DOI: 10.1007/s00520-026-11186-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 22.09.2026. Verfasst von Abby Girard und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine and Community Health, University of Minnesota, Minnesota, MN, USA. girar023@umn.edu. Hauptthemen laut MEDLINE: Sexual Health, Communication Barriers, Genital Neoplasms, Female, Health Personnel. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Despite established clinical guidelines recommending sexual health screening in oncology care, significant gaps in provider-patient communication persist. This study examined the experiences of gynecologic oncology providers regarding sexual health communication to guide the design of a targeted training intervention.
Methods
Semi-structured interviews were conducted with 21 gynecologic oncology healthcare providers, including gynecologic oncologists, nurse practitioners, and physician assistants, practicing across three large healthcare systems in a single Midwestern U.S. state. Interviews were conducted via Zoom, audio recorded, professionally transcribed, and analyzed using inductive thematic analysis.
Results
Two overarching themes were identified: contextual variability of sexual health communication and factors influencing sexual health communication. Providers described variability in the initiation, timing, and content of sexual health discussions, with advanced practice providers reporting greater comfort initiating these conversations than physicians. Key barriers included perceived time constraints, provider and patient discomfort, age-related assumptions, cultural and linguistic challenges, and uncertainty about professional scope of practice. Notably, providers demonstrated awareness of these barriers yet reported difficulty translating that awareness into consistent practice.
Conclusion
Gynecologic oncology providers recognize the importance of sexual health communication but face substantial structural, interpersonal, and cultural barriers that limit consistent implementation. Findings support the need for accessible, skills-based training and system-level strategies that embed sexual health communication as a routine component of gynecologic cancer survivorship care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Family Medicine and Community Health, University of Minnesota, Minnesota, MN, USA. girar023@umn.edu.
- School of Health in Social Sciences, University of Edinburgh, Edinburgh, UK. girar023@umn.edu.
- Department of Family Medicine and Community Health, University of Minnesota, Minnesota, MN, USA.
- Division of Gynecologic Oncology, University of Minnesota, Minneapolis, MN, USA.
- Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Zitieren
APA
Girard, A., von DeWitt, E., Rider, G. N., Geller, M. A., Pratt, R., Vogel, R. I., & Reese, J. B. (2026). Addressing sexual health after cancer: whose job is it anyway? Provider practices and communication barriers. Supportive Care in Cancer, 34(10). https://doi.org/10.1007/s00520-026-11186-9
Vancouver
Girard A, von DeWitt E, Rider GN, Geller MA, Pratt R, Vogel RI, et al. Addressing sexual health after cancer: whose job is it anyway? Provider practices and communication barriers. Supportive Care in Cancer. 2026;34(10). doi:10.1007/s00520-026-11186-9
BibTeX
@article{Girard2026,
author = {Girard, Abby and von DeWitt, Eloise and Rider, G Nic and Geller, Melissa A and Pratt, Rebekah and Vogel, Rachel I and Reese, Jennifer B},
title = {Addressing sexual health after cancer: whose job is it anyway? Provider practices and communication barriers},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {10},
doi = {10.1007/s00520-026-11186-9}
}
EUVIMED